Stocks · Health care · Biological Products, (No Diagnostic Substances)

LENZ Therapeutics, Inc.

LENZ Clue Score42
United States Fiscal year ends December CIK 0001815776 Results filed 28 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Ra Capital Management, L.p.
29 Oct 2026
10% owner
Sell indirect
107,170
$3.36
$360.09K
Ra Capital Management, L.p.
29 Oct 2026
10% owner
Sell indirect
451,998
$3.36
$1.52M
Ra Capital Management, L.p.
29 Oct 2026
10% owner
Sell indirect
2,159,516
$3.36
$7.26M

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 0
History held since 28 Jun 2021